Prospective Bladder Cancer Infrastructure (ProBCI)

Prospective Bladder Cancer Infrastructure: an Infrastructure for Observational and Interventional Bladder Cancer Research (ProBCI)

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04503577

Acronym

ProBCI

Enrollment

3600

Registered

2020-08-07

Start date

2020-10-04

Completion date

2041-12-31

Last updated

2025-08-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bladder Cancer

Keywords

Bladder cancer, Prospective cohort

Brief summary

Prospective nation-wide cohort of high-risk non-muscle-invasive, muscle-invasive and metastatic bladder cancer in the Netherlands

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* Bladder cancer * Any stage except Ta * 18 years or older * Written informed consent

Exclusion criteria

* No

Design outcomes

Primary

Measure	Time frame	Description
Overall survival	10 years	Alive/death/emigrated

Secondary

Measure	Time frame	Description
Progression-free survival	10 yeas	Progression/no progression
Recurrence-free survival	10 yeas	Recurrence/no recurrence
Health-related quality of life	2 years	EQ-5D (EuroQol-Five Dimensions)
Cancer-specific health-related quality of life	2 years	QLQ-C30 (Quality of Life Questionnaire-Cancer)

Countries

Netherlands

Contacts

Primary ContactA. Richters, PhD

a.richters@iknl.nl0031623237842

Outcome results